Karam Sammy 4
4 · ABBOTT LABORATORIES · Filed Feb 22, 2023
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Award
Option (right to buy)
2023-02-17+45,812→ 45,812 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (45,812 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,270 on February 17, 2024, 15,271 on February 17, 2025, and 15,271 on February 17, 2026.